CNE100002Y25
CNE100002Y25
NINGBO MENOVO PHARMACEUTICAL CO
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 9.67B EUR | 7.9B EUR | 9.02B EUR | 4.24B EUR |
Enterprise Value | 9.9B EUR | 8.2B EUR | 9.83B EUR | 5.05B EUR |
Valuation Multiples | ||||
Trailing P/E | 63.22x | 112.92x | 138.1x | 76.68x |
Forward P/E | 20.04x | -- | -- | -- |
Price to Sales | 5.74x | 6.35x | 8.02x | 3.99x |
Price to Book | 3.3x | 2.7x | 3.79x | 1.82x |
EV/Revenue | 5.88x | 6.59x | 8.74x | 4.74x |
EV/EBITDA | 31.24x | 54.13x | 67.24x | 36.84x |
Price to FCF (P/FCF) | -- | 333.15x | -- | 378.16x |
EV/FCF | -- | 345.85x | -- | 449.52x |
FCF Yield | -2.73% | 0.3% | -0.07% | 0.26% |